危重症中高炎症与低炎症表型的时间转换
该研究利用MARS前瞻性观察队列及ALVEOLI、CLOVERS两项随机对照试验数据,纳入第0-4天多时间点有生物标志物的危重症患者,用含血浆IL-8、蛋白C和血清碳酸氢盐的简化分类模型逐日判定高炎症与低炎症表型。MARS中第0天高炎症表型占36.0%,第2天降至15.6%,第4天降至6.3%;ALVEOLI和CLOVERS第0天分别26.4%和24.8%,第3天降至13.4%和5.7%。三个队列中,从第0天高炎症转为低炎症者死亡结局显著优于持续高炎症者,中介分析提示该改善仅小部分归因于器官衰竭缓解。
要点
- MARS队列第0天高炎症表型占36.0%,第2天降至15.6%,第4天降至6.3%。
- ALVEOLI和CLOVERS第0天高炎症表型分别占26.4%和24.8%,第3天分别降至13.4%和5.7%。
- 三个队列中,从高炎症(第0天)转为低炎症者死亡率显著低于持续高炎症者。
- 中介分析提示,转为低炎症带来的死亡改善仅小部分可归因于器官衰竭缓解。
- 高炎症表型比例下降见于危重症早期数日,与是否诊断ARDS无关。
适用人群与场景
- MARS前瞻性观察队列、ALVEOLI随机对照试验(急性呼吸窘迫综合征)和CLOVERS随机对照试验(脓毒症)中第0-4天多时间点有生物标志物数据的危重症患者。
诊断标准与关键阈值
- 使用已验证的分类模型,纳入血浆IL-8、蛋白C和血清碳酸氢盐,逐日判定高炎症与低炎症表型。
研究设计与关键结果
- 研究类型:利用一个前瞻性观察队列(MARS)和两项随机对照试验(ALVEOLI、CLOVERS)数据的分析;MARS、ALVEOLI、CLOVERS分别纳入2407、527、868例患者。
- MARS队列第0天高炎症表型占36.0%,第2天降至15.6%,第4天降至6.3%。
- ALVEOLI和CLOVERS第0天高炎症表型分别占26.4%和24.8%,第3天分别降至13.4%和5.7%。
- 三个队列中,随时间从高炎症(第0天)转为低炎症者的死亡率显著低于持续高炎症患者。
- 中介分析提示,上述死亡改善仅小部分可归因于器官衰竭缓解。
- 高炎症表型比例在危重症早期数日下降,与是否诊断急性呼吸窘迫综合征无关。
- 结论:从高炎症向低炎症转换介导了超越器官衰竭缓解的恢复轨迹。
证据类型、等级与局限
- 证据类型:基于一个前瞻性观察队列和两项随机对照试验数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Systemic molecular phenotypes of critical illness are prognostically informative, yet their temporal kinetics and implications of changing phenotypes remain incompletely understood. Objectives: To determine the temporal nature of the Hyperinflammatory and Hypoinflammatory phenotypes and assess the impact of transition between the phenotypes on mortality. Methods: We used data from one prospective observational cohort (MARS [Molecular Diagnosis and Risk Stratification of Sepsis]) and two randomized controlled trials in acute respiratory distress syndrome (ALVEOLI [Assessment of Low Tidal Volume and Elevated End-Expiratory Pressure to Obviate Lung Injury]) and sepsis (CLOVERS [Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis]). Critically ill patients with biomarkers available at multiple time points (Days 0-4) were included. We used a validated classifier model incorporating plasma IL-8, protein C, and serum bicarbonate to assign phenotypes on each day. We determined the association of longitudinal phenotype transition and 90-day all-cause mortality. Measurements and Main Results: Data from 2,407, 527, and 868 patients were included in MARS, ALVEOLI, and CLOVERS, respectively. In MARS, 36.0% were classified by the parsimonious model as Hyperinflammatory at Day 0, decreasing to 15.6% by Day 2 and 6.3% by Day 4. In ALVEOLI and CLOVERS, 26.4% and 24.8% of patients were Hyperinflammatory at Day 0, decreasing to 13.4% and 5.7% at Day 3, respectively. In all three cohorts, switching classification from Hyperinflammatory (Day 0) to Hypoinflammatory over time was associated with significantly improved mortality compared with persistently Hyperinflammatory patients. Mediation analysis indicated that only a minor proportion of this improvement could be attributed to ameliorating organ failure. Conclusions: The prevalence of the Hyperinflammatory phenotype, as assigned using a parsimonious biomarker classifier model, decreases over the first several days of critical illness, irrespective of acute respiratory distress syndrome diagnosis. The transition from Hyperinflammatory to Hypoinflammatory mediates a trajectory toward recovery beyond the resolution of organ failure.
参考来源
- van Amstel RBE, Bartek B, Vlaar APJ, et al. Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness. Am J Respir Crit Care Med. 2025. PMID: 39642348. doi:10.1164/rccm.202406-1241OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。